Medigen Vaccine Biologics Cash Flow-to-Debt Ratio
Medigen Vaccine Biologics cash flow-to-debt ratio. Medigen Vaccine Biologics (6547) has a Cash Flow-to-Debt Ratio of -0.08x as of June 2026, meaning its operating cash flow of NT$-91.20 Million could theoretically repay 0% of its total liabilities (NT$1.21 Billion) in one year. Check Medigen Vaccine Biologics (6547) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Medigen Vaccine Biologics (2012–2025)
Cash flow-to-debt ratio of Medigen Vaccine Biologics from 2012 to 2025. Historical debt coverage capacity for Medigen Vaccine Biologics across 14 annual periods. Check Medigen Vaccine Biologics cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Medigen Vaccine Biologics Cash Flow-to-Debt Ratio by Year (2012–2025)
Medigen Vaccine Biologics cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Medigen Vaccine Biologics. For the full cash flow conversion analysis, see cash flow conversion of Medigen Vaccine Biologics.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.11x | NT$-49.09 Million | NT$454.64 Million | ▼ -236.2% |
| 2024 | 0.08x | NT$40.75 Million | NT$513.92 Million | ▲ +137.3% |
| 2023 | -0.21x | NT$-477.75 Million | NT$2.25 Billion | ▲ +55.2% |
| 2022 | -0.47x | NT$-1.10 Billion | NT$2.32 Billion | ▼ -151.0% |
| 2021 | 0.93x | NT$579.89 Million | NT$622.95 Million | ▲ +155.1% |
| 2020 | -1.69x | NT$-589.97 Million | NT$349.40 Million | ▼ -232.2% |
| 2019 | -0.51x | NT$-462.65 Million | NT$910.28 Million | ▲ +18.5% |
| 2018 | -0.62x | NT$-356.33 Million | NT$571.10 Million | ▼ -76.9% |
| 2017 | -0.35x | NT$-217.03 Million | NT$615.41 Million | ▲ +24.9% |
| 2016 | -0.47x | NT$-163.37 Million | NT$347.90 Million | ▼ -167.1% |
| 2015 | 0.70x | NT$216.26 Million | NT$309.19 Million | ▲ +118.5% |
| 2014 | -3.78x | NT$-513.98 Million | NT$135.95 Million | ▼ -1.7% |
| 2013 | -3.72x | NT$-72.36 Million | NT$19.46 Million | ▼ -1404.9% |
| 2012 | -0.25x | NT$-5.47 Million | NT$22.15 Million | — |